Loading...
Recent Press
1/10:
Emory and Virtually Better PTSD Experts to Train Armed Services Mental Health Clinicians
1/10:
Emory Will Partner with GlaxoSmithKline on Drug Research for Neglected Tropical Diseases
1/10:
Grady Testing Breakthrough for Traumatic Brain Injury
12/09:
Neuronetics NeuroStar TMS Theraphy
TM
#5 Top Invention of 2009 by CNN
11/09:
Scientist on a Conveyor Belt of Discovery
10/09:
GeoVax Moving Headquarters to Smyrna
10/09:
Online H1N1 Flu Response Center Taps Emory Assessment Tool
9/09:
BHR Pharma Announces Phase III Study of Progesterone
8/09:
Alimera Sciences Closes $5 Million in Extended Series C Financing
7/09:
Gilead Sciences and Tibotec Pharmaceuticals to Develop New Fixed-Dose Combination of Truvada(R) and TMC278
6/09:
Emory Announces Phase III Study of Progesterone for Traumatic Brain Injury
6/09:
Technology Transfer Tools Drive Discovery and Protect Researchers
6/09:
NIH Grant Will Allow Nationwide Network to Study Effects of Hormone's Effectiveness
5/09:
Emory Starts Drug Discovery Center
5/09:
New Emory Institute for Drug Discovery Announced
5/09:
Emory, Australian Vaccine Centers Announce Alliance
5/09:
H1N1 Research Includes Monoclonal Antibodies, Virus-Like Particles, Virus Transmission Studies
5/09:
Sound Science: Todd Sherer - Technology Transfer Bringing Research to the People
5/09:
Johnson & Johnson Completes Aquisition of Cougar Biotechnology
5/09:
OTT 3rd Annual Celebration of Technology and Innovation, Marchl 31st
5/09:
Trail by Fire: New Antibody Method Gets Big Test
5/09:
Taking Biotechnology to the Market
5/09:
Lifesaving Science
4/09:
Roche and Pharmasset Initiate Phase IIb Clinical Trial of R7128
4/09:
Winship Cancer Institute Announces NCI Cancer Center Designation
3/09:
Pharmasset Initiates First Time in Human Study of PSI-7851 for the Treatment of Hepatitis C (HCV)
2/09:
Emory OTT Ranked 16th Nationally in Licensing Revenue from Research Discoveries
1/09:
Pharmasset Announces $45.5 Million Registered Direct Offering of Common Stock
Previous Breaking News